Search

Kevin S. Orwig

Examiner (ID: 15505, Phone: (571)270-5869 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
3991, 1658, 1611
Total Applications
910
Issued Applications
256
Pending Applications
48
Abandoned Applications
609

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17602900 [patent_doc_number] => 11331369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Endoparasitic depsipeptides [patent_app_type] => utility [patent_app_number] => 16/652136 [patent_app_country] => US [patent_app_date] => 2018-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53038 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652136 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/652136
Endoparasitic depsipeptides Nov 27, 2018 Issued
Array ( [id] => 19058431 [patent_doc_number] => 11937618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Method for providing a proteinaceous composition without pH adjustment [patent_app_type] => utility [patent_app_number] => 16/198851 [patent_app_country] => US [patent_app_date] => 2018-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2654 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198851 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/198851
Method for providing a proteinaceous composition without pH adjustment Nov 21, 2018 Issued
Array ( [id] => 16435710 [patent_doc_number] => 20200353035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => TREATMENT OF PARASITIC INFECTIONS OF FISH SURFACES [patent_app_type] => utility [patent_app_number] => 16/764437 [patent_app_country] => US [patent_app_date] => 2018-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764437 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/764437
TREATMENT OF PARASITIC INFECTIONS OF FISH SURFACES Nov 19, 2018 Abandoned
Array ( [id] => 18152074 [patent_doc_number] => 11565024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Lysostaphin containing synthetic hydrogel carriers for bone repair [patent_app_type] => utility [patent_app_number] => 16/191685 [patent_app_country] => US [patent_app_date] => 2018-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 126 [patent_no_of_words] => 8700 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191685 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/191685
Lysostaphin containing synthetic hydrogel carriers for bone repair Nov 14, 2018 Issued
Array ( [id] => 14016191 [patent_doc_number] => 20190070089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => Stable Silk Protein Fragment Compositions [patent_app_type] => utility [patent_app_number] => 16/184098 [patent_app_country] => US [patent_app_date] => 2018-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16184098 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/184098
Stable silk fibroin based pharmaceutical formulations Nov 7, 2018 Issued
Array ( [id] => 17975527 [patent_doc_number] => 11492375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Cyclic peptide immunomodulators [patent_app_type] => utility [patent_app_number] => 16/753666 [patent_app_country] => US [patent_app_date] => 2018-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41146 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 492 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753666 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/753666
Cyclic peptide immunomodulators Oct 1, 2018 Issued
Array ( [id] => 14403493 [patent_doc_number] => 20190167590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same [patent_app_type] => utility [patent_app_number] => 16/142639 [patent_app_country] => US [patent_app_date] => 2018-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142639 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/142639
Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same Sep 25, 2018 Abandoned
Array ( [id] => 16252160 [patent_doc_number] => 20200261534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => NEW TREATMENTS OF MULTIPLE MYELOMA [patent_app_type] => utility [patent_app_number] => 16/651983 [patent_app_country] => US [patent_app_date] => 2018-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19204 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651983 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651983
NEW TREATMENTS OF MULTIPLE MYELOMA Sep 9, 2018 Abandoned
Array ( [id] => 16268822 [patent_doc_number] => 20200270309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/646576 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646576 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/646576
MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF Sep 6, 2018 Abandoned
16/120549 GROWTH DIFFERENTIATION FACTOR 11 (GDF-11) FOR TREATMENT OF DIASTOLIC HEART FAILURE Sep 3, 2018 Pending
Array ( [id] => 16139113 [patent_doc_number] => 10702610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors [patent_app_type] => utility [patent_app_number] => 16/116045 [patent_app_country] => US [patent_app_date] => 2018-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4346 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116045 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/116045
Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors Aug 28, 2018 Issued
Array ( [id] => 16806149 [patent_doc_number] => 20210128702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/635714 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635714 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/635714
USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS Aug 12, 2018 Abandoned
Array ( [id] => 16376335 [patent_doc_number] => 20200325177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/635070 [patent_app_country] => US [patent_app_date] => 2018-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88270 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635070 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/635070
METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF Jul 30, 2018 Abandoned
Array ( [id] => 13549135 [patent_doc_number] => 20180326115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => FIBRINOGEN-BASED TISSUE ADHESIVE PATCHES [patent_app_type] => utility [patent_app_number] => 16/041903 [patent_app_country] => US [patent_app_date] => 2018-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9430 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041903 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/041903
Fibrinogen-based tissue adhesive patches Jul 22, 2018 Issued
Array ( [id] => 13533773 [patent_doc_number] => 20180318429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => USE OF HYDROPHOBIC ORGANIC ACIDS TO INCREASE HYDROPHOBICITY OF PROTEINS AND PROTEIN CONJUGATES [patent_app_type] => utility [patent_app_number] => 16/032952 [patent_app_country] => US [patent_app_date] => 2018-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16032952 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/032952
Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates Jul 10, 2018 Issued
Array ( [id] => 13519243 [patent_doc_number] => 20180311164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => TREATING FUNGAL INFECTION OF THE NAIL UNIT [patent_app_type] => utility [patent_app_number] => 16/025979 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025979 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/025979
TREATING FUNGAL INFECTION OF THE NAIL UNIT Jul 1, 2018 Abandoned
Array ( [id] => 15483209 [patent_doc_number] => 10556937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Methods for the production of a cosmetic composition comprising leukolectin and uses thereof [patent_app_type] => utility [patent_app_number] => 16/010962 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18376 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010962 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/010962
Methods for the production of a cosmetic composition comprising leukolectin and uses thereof Jun 17, 2018 Issued
Array ( [id] => 15740561 [patent_doc_number] => 20200109168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => MACROCYCLIC PEPTIDES AND DERIVATIVES THEREOF WITH OPIOID ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/622749 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622749 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/622749
Macrocyclic peptides and derivatives thereof with opioid activity Jun 14, 2018 Issued
Array ( [id] => 13424771 [patent_doc_number] => 20180263928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => AMANTADINE COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/985300 [patent_app_country] => US [patent_app_date] => 2018-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985300 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/985300
AMANTADINE COMPOSITIONS AND METHODS OF USE May 20, 2018 Abandoned
Array ( [id] => 13729357 [patent_doc_number] => 20180369146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT [patent_app_type] => utility [patent_app_number] => 15/982287 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982287 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/982287
METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT May 16, 2018 Abandoned
Menu